Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Jun Shengtai Logo
Jun Shengtai Growth Score
53
CB Rank
79433
Heat Score
70
Jun Shengtai engages in the development of original drugs in the field of chronic liver disease.
Founded
obfuscation
PrivateSeries C Shenzhen, Guangdong, China51-100 hightidetx.com/cn/contact/contact.html
Biotechnology
Health Care
Medical
Pharmaceutical
Overview

Jun Shengtai
Total Funding
obfuscation
Growth Score
53
Heat Score
70

Total Funding
obfuscation
obfuscation
Series C raised
obfuscation
Growth Score53
-2 pts
in past quarter
Heat Score 70
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Jun Shengtai

CB Rank
79433
Jun Shengtai engages in the development of original drugs in the field of chronic liver disease.
Founded
obfuscation
PrivateSeries C Shenzhen, Guangdong, China51-100 hightidetx.com/cn/contact/contact.html
Biotechnology
Health Care
Medical
Pharmaceutical

Funding Rounds

Series C
OBF
in
obfuscation

Details

Legal Name Shenzhen Junshengtai Biotechnology Co., Ltd.
Also Known As HIGHTIDE
Operating Status Active
Company Type For Profit
About the Company
Jun Shengtai engages in the development of original drugs in the field of chronic liver disease.
Contact Email info@hightidetx.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Berberine Ursodeoxycholate (HTD1801)
An oral drug candidate targeting chronic metabolic and liver diseases by modulating gut-liver inflammation and metabolism through dual mechanisms.
Rimtoregtide (HTD4010)
A drug candidate in preclinical development for liver and metabolic diseases, focusing on novel therapeutic mechanisms.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series C - Jun Shengtai Logo
Series C - Jun Shengtai
5
obfuscation
China Development Bank Capital, Guangdong Traditional Chinese Medicine Health FundSeries C
obfuscation
Series C - Jun Shengtai Logo
Series C - Jun Shengtai
5
obfuscation
China Development Bank Capital, Guangdong Traditional Chinese Medicine Health FundSeries C
obfuscation
Series C - Jun Shengtai Logo
Series C - Jun Shengtai
5
obfuscation
China Development Bank Capital, Guangdong Traditional Chinese Medicine Health FundSeries C
obfuscation
Series C - Jun Shengtai Logo
Series C - Jun Shengtai
5
obfuscation
China Development Bank Capital, Guangdong Traditional Chinese Medicine Health FundSeries C
obfuscation
Series C - Jun Shengtai Logo
Series C - Jun Shengtai
5
obfuscation
China Development Bank Capital, Guangdong Traditional Chinese Medicine Health FundSeries C

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series C - Jun Shengtai Logo
Series C - Jun Shengtai
5
obfuscation
China Development Bank Capital, Guangdong Traditional Chinese Medicine Health FundSeries C
obfuscation
Series C - Jun Shengtai Logo
Series C - Jun Shengtai
5
obfuscation
China Development Bank Capital, Guangdong Traditional Chinese Medicine Health FundSeries C
obfuscation
Series C - Jun Shengtai Logo
Series C - Jun Shengtai
5
obfuscation
China Development Bank Capital, Guangdong Traditional Chinese Medicine Health FundSeries C
obfuscation
Series C - Jun Shengtai Logo
Series C - Jun Shengtai
5
obfuscation
China Development Bank Capital, Guangdong Traditional Chinese Medicine Health FundSeries C
obfuscation
Series C - Jun Shengtai Logo
Series C - Jun Shengtai
5
obfuscation
China Development Bank Capital, Guangdong Traditional Chinese Medicine Health FundSeries C

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100
News
Technology
View Tech Report

IT Spend

$1.1MThis year, Jun Shengtai is projected to spend $1.1M on IT, according to Aberdeen.

Total IP

47The intellectual property of Jun Shengtai includes 44 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Jun Shengtai has registered 3 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Jun Shengtai's headquarters? Jun Shengtai is located in Shenzhen, Guangdong, China.Who invested in Jun Shengtai? Jun Shengtai has 5 investors including Guangdong Traditional Chinese Medicine Health Fund and  Yuthai Investment.When was the last funding round for Jun Shengtai? Jun Shengtai closed its last funding round on
obfuscation
from a Series C round.Who are Jun Shengtai's competitors? Alternatives and possible competitors to Jun Shengtai may include Eli Lilly, Alnylam Pharmaceuticals, and  Novo Nordisk.How much funding has Jun Shengtai raised to date? Jun Shengtai has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5d46e5f 1)
|